What are the diagnostic criteria for disseminated intravascular coagulation (DIC)?

Diagnosis of Disseminated Intravascular Coagulation

Use the ISTH overt DIC scoring system as your primary diagnostic tool, requiring a score ≥5 based on platelet count, PT prolongation, elevated D-dimer/FDP, and low fibrinogen; for septic patients, apply the two-step approach by first screening with the SIC score (≥4) to detect early-phase DIC before progression to overt disease. 1

Updated 2025 ISTH Definition

DIC is now defined as an acquired, life-threatening intravascular disorder characterized by systemic coagulation activation, dysregulated fibrinolysis, and endothelial injury, resulting in microthrombosis that progresses from a potentially asymptomatic early phase to an advanced phase with hemorrhage and/or organ dysfunction. 2, 3

The 2025 framework introduces a phase-based classification: Pre-DIC, early-phase DIC (also called subclinical or compensated DIC), and overt DIC. 2, 3

ISTH Overt DIC Scoring System (Primary Diagnostic Tool)

Calculate the following score; ≥5 points = overt DIC: 1

Platelet Count

• 2 points: <50 × 10⁹/L 1
• 1 point: ≥50 to <100 × 10⁹/L 1

D-dimer/FDP Elevation

• 3 points: >7× upper normal limit (revised 2025 threshold) 2
• 2 points: >3× to ≤7× upper normal limit (revised 2025 threshold) 2

Prothrombin Time Prolongation

• 2 points: ≥6 seconds prolonged (PT ratio >1.4) 1
• 1 point: ≥3 to <6 seconds prolonged (PT ratio >1.2 to ≤1.4) 1

Fibrinogen Level

• 1 point: <1.0 g/L 1

This scoring system emphasizes laboratory markers over clinical manifestations, with increased weight given to fibrin-related markers (D-dimer/FDP) compared to platelet count. 1

Two-Step Sequential Approach for Sepsis-Associated DIC

For septic patients specifically, apply this sequential screening strategy to detect DIC at an earlier, more treatable phase: 1

Step 1: Sepsis-Induced Coagulopathy (SIC) Score (Early Detection)

Calculate the following score; ≥4 points = SIC/early-phase DIC: 1

• Platelet count:

  • 2 points: <100 × 10⁹/L 1
  • 1 point: ≥100 to <150 × 10⁹/L 1

• PT ratio:

  • 2 points: >1.4 1
  • 1 point: >1.2 to ≤1.4 1

• SOFA score (sum of respiratory, cardiovascular, hepatic, renal components):

  • 2 points: ≥2 1
  • 1 point: 1 1

The SIC criteria identify patients at an earlier phase when anticoagulant therapy may still be beneficial, before progression to advanced coagulopathy where illness may no longer be amenable to treatment. 1

Step 2: Progress to Overt DIC Scoring

If SIC is positive, repeat the full overt DIC scoring system (described above) to determine if the patient has progressed to advanced disease. 1

Screening for overt DIC on ICU admission is associated with lower mortality, and this association strengthens if screening is repeated 2 days later, suggesting that DIC screening itself may lead to improved outcomes. 1

Essential Laboratory Panel for DIC Diagnosis

Order this core panel when DIC is suspected: 4

• Platelet count 4
• Prothrombin time (PT) 4
• Activated partial thromboplastin time (aPTT) 4
• Fibrinogen level 4
• D-dimer or fibrin degradation products (FDP) 4

Pattern Recognition for DIC

The combined presence of these four abnormalities is highly suggestive of DIC: 4

1. Thrombocytopenia: ≤100 × 10⁹/L, especially ≤50 × 10⁹/L 4
2. Prolonged PT: ≥1.5× mean normal 4
3. Prolonged aPTT: ≥1.5× mean normal and beyond what dilution alone would cause 4
4. Elevated D-dimer/FDP: The combined D-dimer/FDP measurement provides the highest diagnostic efficiency 4

Critically low fibrinogen (<1.0 g/L) is a strong indicator of DIC. 4

Serial Monitoring is Mandatory

DIC evolves rapidly; single time-point measurements are misleading. 4

• Repeat the core laboratory panel every 24–48 hours to capture progressive changes in coagulation parameters. 4
• Serial testing should be performed before overt microvascular bleeding becomes apparent. 4
• Rapid (hour-to-day) shifts in coagulation test results favor true DIC over the relatively stable hemostatic abnormalities seen in chronic liver disease. 4

Confirmatory Adjunct Tests (When Differentiation is Needed)

Add these tests when you need to differentiate DIC from liver disease or other mimics: 4

• Antithrombin activity: Declines as consumptive coagulopathy progresses; falling levels correlate with greater severity and poorer prognosis 4
• Factor VIII and von Willebrand factor: Low or decreasing levels are characteristic of consumptive coagulopathy and help differentiate true DIC from chronic liver disease, where these factors are usually preserved 4

Disease-Specific Considerations

Trauma Patients

Laboratory abnormalities that mimic DIC (prolonged PT/aPTT, low platelets/fibrinogen, high D-dimer) often reflect hemodilution, shock, and hyperfibrinolysis rather than true microthrombi formation. 4 A trauma-specific revision of the JAAM DIC criteria using different cutoff values (PT-INR 1.080, FDP 116.0 μg/mL, platelet count 17.0 × 10⁴/μL) outperforms conventional scoring for predicting mortality and massive transfusion in severely injured patients. 5

Sepsis

The SIC score is specifically designed for septic patients and should be used as the initial screening tool. 1 The JAAM DIC criteria, which add SIRS scoring and eliminate fibrinogen scoring, are commonly used in Japan for acute-onset DIC in sepsis and trauma. 1

Malignancy and Other Etiologies

The 2025 update emphasizes that diagnostic criteria should be tailored to the underlying disease, as DIC mechanisms vary based on etiology (tissue factor, cytokines, etc.). 2, 6

Phenotype Classification

The 2025 criteria classify DIC into two phenotypes: 2

• Thrombotic DIC: Marked by microvascular thrombosis and organ dysfunction 2
• Hemorrhagic DIC: Characterized by bleeding due to consumption of coagulation factors 2

Diagnostic Performance of Different Scoring Systems

Multiple DIC scoring systems exist with different strengths: 7

• ISTH overt DIC: High specificity for DIC; odds ratio for death 2.55 (95% CI 1.65–3.95) 7
• JAAM DIC: High sensitivity for DIC; odds ratio for death 1.99 (95% CI 1.19–3.32) 7
• JMHW (Japanese Ministry): Odds ratio for death 1.88 (95% CI 1.22–2.90) 7

The concordance between ISTH and JMHW criteria is 67.4%, with only 2.0% of non-DIC patients by JMHW criteria diagnosed with overt DIC by ISTH criteria, suggesting that ISTH criteria capture typical DIC cases. 8

Common Pitfalls to Avoid

• Relying on isolated laboratory values: In isolation, aPTT yields only 57% diagnostic efficiency and platelet count only 67% efficiency, underscoring the need for a combined panel 4
• Single time-point assessment: DIC is a dynamic process requiring serial measurements 4, 9
• Ignoring clinical context: Always integrate laboratory data with the underlying clinical trigger (sepsis, malignancy, trauma, obstetric complications) 4
• Delaying diagnosis in sepsis: Use the SIC score to detect early-phase DIC when treatment is most effective, before progression to overt disease 1
• Confusing trauma-related coagulopathy with DIC: Trauma patients require different cutoff values and interpretation 4, 5